Natixis Advisors, L.P. Corcept Therapeutics Inc Transaction History
Natixis Advisors, L.P.
- $51.3 Billion
- Q3 2024
A detailed history of Natixis Advisors, L.P. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Natixis Advisors, L.P. holds 28,144 shares of CORT stock, worth $1.56 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,144
Previous 20,660
36.22%
Holding current value
$1.56 Million
Previous $671,000
94.19%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CORT
# of Institutions
350Shares Held
86.1MCall Options Held
1.12MPut Options Held
667K-
Black Rock Inc. New York, NY16.5MShares$915 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$553 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.27MShares$457 Million14.93% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.51MShares$360 Million0.48% of portfolio
-
Parallel Advisors, LLC3.81MShares$211 Million4.22% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $5.92B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...